Skip to main content
. 2022 Mar 1;32(7):4352–4360. doi: 10.1007/s00330-022-08566-0

Table 2.

Descriptive table reporting prevalence of cardiovascular risk factors and main comorbidities among consecutive patients with a CMR diagnosis of myocarditis and/or pericarditis, observed in the period March–July 2021. Our cohort is categorized into 3 groups: vaccinated: n = 27 vaccinated patients, COVID-19+ (unvaccinated): n = 14 unvaccinated patients with diagnosis of acute or healed COVID-19 disease (based on clinical presentation and PCR confirmation), and COVID-19− (unvaccinated): n = 197 patients, unvaccinated and without history of COVID-19 disease. Definitions of listed risk factors and comorbidities: hypertension = systolic blood pressure ≥ 130 mmHg or a diastolic blood pressure ≥ 80 mmHg or current medical treatment for hypertension; diabetes = fasting glucose > 126 mg/dL or current treatment; smoking = current smoker or ex-smoker with suspension less than 5 years before observation; hyperlipidemia = LDL > 130 mg/dL or current treatment; moderate/high physical activity = at least 150 min per week of moderate-intensity aerobic activity or 75 min per week of vigorous aerobic activity, or a combination of both; autoimmunities = history of autoimmune diseases

Age years, (mean) Gender (%male) BMI (kg/m2) (mean) Hypertension (%) Diabetes (%) Smoking (%) Moderate/high physical activity (%) Hyperlipidemia (%) Autoimmunities (%)
Vaccinated 36.6 92.6 25.9 22.8 6.2 20.4 35.7 22.6 11.1
COVID-19+ (unvaccinated) 46.2 84.8 26.2 25.5 13 29.7 22.4 44.8 9.8
COVID-19− (unvaccinated) 38.2 82.5 24.3 20 10.1 26.5 33.8 29.1 7.2